Pharma Panels
Three pharma-focused panels will be held during the 2025 American Peptide Symposium to engage thought leaders across industry.
How to Register: This add-on can be purchased when you register for the Symposium. If you have already registered, please email iuconfs@iu.edu or call 812-855-4224, U.S. and Worldwide, or 800-933-9330, U.S. only, between 8am and 5pm Eastern time, UTC -4, Monday-Friday. Our team will be happy to help you add the Pharma Panels to your registration.
The panels will take place from 8:00 PM – 10:00 PM on Monday, Tuesday, and Wednesday night. The cost is $400, to gain access to all three panels, in addition to conference registration. The total number of participants will be limited to 100 for each panel to encourage discussion across the group. The panels will cover the following topics.
Beyond Potency: PK, Formulation, IP, and More
Monday 08:00 pm - 10:00 pm
Moderated by Nicolas Boyer
Principal Scientist, Merck
Panelists:
Elisabetta Bianchi, Director, Discovery Chemistry, Curium
John DiMaio, Patent Attorney, Senior Associate, Hodgson Russ LLP
Ruchia Duggal, Principal Scientist, Merck
Sivaneswary Genapathy, Associate Director, Bicycle Therapeutics
Christopher John, Scientific Director, Johnson and Johnson Innovative Medicines
Designing and Developing Orally Available Peptides
Tuesday 08:00 pm - 10:00 pm
Moderated by Kaustav Biswas,
Sr. Principal Scientist/Sr. Director, Merck
Panelists:
Ashok Bhandari, Executive Vice President, Chief Drug Discovery and Preclinical Development Officer, Protagonist Therapeutics
Gaurav Bhardwaj, Assistant Professor, University of Washington, Co-Founder Vilya
Callie Bryan, Scientific Director and Peptide Lead, Global Discovery Chemistry, Johnson and Johnson Innovative Medicines
Ryuji Hayashi, Group Head, Discovery Chemistry, Chugai Pharmaceutical Co., Ltd.
Josh Schwochert, Co-founder and CSO, Unnatural Products
Sustainability in Peptide Manufacturing
Wednesday 08:00 pm - 10:00 pm
Moderated by Michael Kopach
Associate VP, Eli Lilly
Panelists:
Fernando Albericio, Professor, University of KwaZulu-Natal
Matthew Bio, President and CEO, Snapdragon
Stefan Eissler, Vice President Peptide Manufacturing Upstream, Bachem
Susan Zultanski, Principal Scientist, Merck